Fresenius Medical Care is the world’s leading provider of products and services for individuals with end stage renal disease, of which around 3.9 million patients worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in the case of kidney failure. As a company, we offer both products and services along the entire dialysis value chain from a single source. Globally, we care for approximately 345,000 patients in our network of over 4,100 dialysis clinics and 42 production sites across all continents. 

Fresenius Medical Care aims to further consolidate its expertise and to use this competence as a basis for sustainable, profitable growth. We aim to continuously improve our patients’ quality of life by offering them high-quality products as well as innovative technologies and treatment concepts with the aim of fostering better clinical outcomes.